Could ketamine ease sickle cell pain in kids? new study seeks answers
NCT ID NCT07369024
First seen Feb 01, 2026 · Last updated Apr 28, 2026 · Updated 9 times
Summary
This study is testing whether adding a low dose of ketamine to standard pain medicine (opioids) can better relieve severe pain from sickle cell disease in children and young adults aged 5 to 20. Participants will either get standard care plus ketamine or standard care plus a placebo. The goal is to see if ketamine reduces the amount of opioid needed and improves pain scores.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PAIN MANAGEMENT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Harbor UCLA Medical Center
RECRUITINGTorrance, California, 90509, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.